Azmi Nabulsi
2020
In 2020, Azmi Nabulsi earned a total compensation of $2.4M as Chief Operating Officer at Phathom Pharmaceuticals, a 345% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,281 |
|---|---|
| Option Awards | $1,314,243 |
| Salary | $445,065 |
| Stock Awards | $322,000 |
| Other | $14,625 |
| Total | $2,364,214 |
Nabulsi received $1.3M in option awards, accounting for 56% of the total pay in 2020.
Nabulsi also received $268.3K in non-equity incentive plan, $445.1K in salary, $322K in stock awards and $14.6K in other compensation.
Rankings
In 2020, Azmi Nabulsi's compensation ranked 4,797th out of 13,090 executives tracked by ExecPay. In other words, Nabulsi earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,797 out of 13,090 | 63rd |
Division Manufacturing | 1,952 out of 5,621 | 65th |
Major group Chemicals And Allied Products | 767 out of 2,254 | 66th |
Industry group Drugs | 660 out of 1,954 | 66th |
Industry Pharmaceutical Preparations | 499 out of 1,459 | 66th |
Source: SEC filing on April 6, 2021.
Nabulsi's colleagues
We found two more compensation records of executives who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2020.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020